Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Menopause01:28

Menopause

5.1K
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
5.1K
Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

2.3K
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
2.3K
Signs of Puberty01:27

Signs of Puberty

2.0K
Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
2.0K
Psychosexual Stages of Personality: Genital01:23

Psychosexual Stages of Personality: Genital

2.2K
The genital stage is the final phase of Sigmund Freud's theory of psychosexual development, beginning at puberty, around age 12. During this stage, sexual energy shifts from self-focused interests to external individuals, marking the development of mature adult sexuality. Freud saw this phase as a time of sexual reawakening, with desires directed toward others outside the family. A healthy transition into this stage, according to Freud, signifies the emergence of two key aspects of adult...
2.2K
Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

4.8K
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
4.8K
Bone Disorders01:29

Bone Disorders

7.8K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
7.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial: Menopause and mental health.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2026
Same author

Anti-Mullerian Hormone Rebound and Estradiol Changes in the Study of Women's Health Across the Nation.

Fertility and sterility·2026
Same author

Disparities in genetic testing: Evaluation of reproductive carrier screening in the United States.

Genetics in medicine : official journal of the American College of Medical Genetics·2026
Same author

Single-Visit Long-Acting Reversible Contraception (LARC) Insertion Practices Before and After Implementation of Practice Changes Including Telehealth Due to the COVID-19 Pandemic in North Carolina.

North Carolina medical journal·2026
Same author

Substance use and menopausal hormone therapy: Treatment initiation and interruption among US women with and without HIV, 2008-2019.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2026
Same author

Early onset, maintenance of effect, and day-/night-time findings following fezolinetant treatment for moderate to severe vasomotor symptoms associated with menopause: A pooled phase 3 analysis.

Maturitas·2025

Related Experiment Video

Updated: Apr 4, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

13.0K

Menopause and Sexuality.

Kimberley Thornton1, Judi Chervenak1, Genevieve Neal-Perry2

  • 1Department of Obstetrics and Gynecology, Montefiore Medical Center, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Mazer Building Room 322, Bronx, NY 10461, USA.

Endocrinology and Metabolism Clinics of North America
|August 29, 2015
PubMed
Summary

Sexual dysfunction is common in menopausal women, impacting quality of life. Identifying causes is key for effective treatment and improved sexual health during menopause.

Keywords:
Hormone therapyHypoactive sexual desire disorderMenopauseSexualityVulvovaginal atrophy

More Related Videos

A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice
14:26

A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice

Published on: April 7, 2014

16.4K
Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats
08:56

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats

Published on: April 7, 2023

1.5K

Related Experiment Videos

Last Updated: Apr 4, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

13.0K
A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice
14:26

A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice

Published on: April 7, 2014

16.4K
Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats
08:56

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats

Published on: April 7, 2023

1.5K

Area of Science:

  • Reproductive Health
  • Gerontology
  • Women's Health

Background:

  • Sexuality is integral to women's lives, yet sexual function declines with age during menopause.
  • This decline can significantly reduce quality of life, necessitating medical attention.
  • Physician recognition of sexual dysfunction is crucial for timely and effective care.

Purpose of the Study:

  • To highlight the importance of addressing sexual dysfunction in menopausal women.
  • To underscore the link between age-related sexual decline and quality of life.
  • To emphasize the need for identifying the etiology of sexual dysfunction for targeted treatment.

Main Methods:

  • Review of factors contributing to sexual dysfunction in menopausal women.
  • Analysis of the impact of age-related sexual decline on quality of life.
  • Discussion of diagnostic approaches to identify the causes of sexual dysfunction.

Main Results:

  • Sexual dysfunction prevalence increases with age in menopausal women.
  • Multiple factors contribute to sexual dysfunction, including psychosocial issues, medication side effects, vulvovaginal atrophy, chronic illness, and hypoactive sexual desire disorder.
  • Identifying specific etiologies and modifiable factors is essential for treatment.

Conclusions:

  • Sexual dysfunction is a significant concern for menopausal women, affecting their quality of life.
  • A comprehensive approach to identify the underlying causes of sexual dysfunction is necessary.
  • Targeted treatments based on identified etiologies can improve sexual health outcomes in menopausal women.